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Abstract
Background: SL3-2 is a unique polytropic murine gammaretroviral isolate that is only able to infect murine cells.
We have previously shown that two mutations R212G and T213I located on the surface of the receptor binding
domain in a region designated the VR3 loop can alter the species tropism of this envelope protein. This location
suggests that the VR3 loop composition has an influence on receptor interaction and thereby affects binding as
well as superinfection resistance. In order to investigate this further, we have studied the binding and interference
patterns of the SL3-2 envelope and its mutants.
Results: We find unexpectedly that wild type SL3-2 envelope binds equally well to both permissive and non-
permissive cells, indicating a post binding defect when interacting with the human Xpr1. Using replication
competent viruses containing envelopes from SL3-2 or its mutants we find that the same amino acid mutations
can dramatically alter the interference profile of this polytropic ENV, suggesting that the same amino acid changes
that cause the post binding defect also influence interaction with the receptor.
Conclusions: The envelope protein of SL3-2 MLV shows an entry defect on non-murine cells. This is coupled to a
dramatically reduced ability to interfere with entry of other polytropic viruses. Two point mutations in the VR3 loop
of the receptor binding domain of this envelope result both in a much increased interference ability and in
removing the post-binding defect on non-murine cells, suggesting that both of these phenotypes are a
consequence of insufficient interaction between the envelope and the receptor
Background
Retroviruses enter their host cells by binding to specific
cellular proteins followed by fusion of viral and cellular
membranes. This interaction is mediated by the viral
envelope glycoproteins. The envelope protein is a single
gene product that is post-translationally cleaved to give
a surface subunit (SU), which is responsible for binding
to the receptor, and a transmembrane subunit (TM)
that mediates the fusion of viral and cellular
membranes.
The surface subunits of different viruses have evolved
to use different cellular proteins as receptors. Even
among closely related viruses, receptor usage can be
markedly different. This is indeed the case for gammare-
troviruses of murine and other species. At least five
different receptors have been identified for this group
including mCAT1 [1-3], Pit1 [4], Pit2 [5], Xpr1 [6-8]
and Smit1 [9]. The greatest variation in species tropism
is found in viruses that use Xpr1 as receptor. Within
this group, xenotropic viruses can infect cells of differ-
ent species but not those of murine origin, while poly-
tropic viruses can use the Xpr1 receptor on cells of
many different species including murine cells. Finally
SL3-2 is a unique isolate of the polytropic virus group
able to infect only murine cells [10,11]. The determinant
for the limited species tropism of SL3-2 was mapped to
two amino acids in an exposed loop, the VR3 loop, in
the receptor binding domain of the surface subunit not
previously implicated in receptor interaction. Thus,
mutation of arginine 212 and threonine 213 to glycine
212 and isoleucine 213, enables the SL3-2 envelope to
efficiently use the human and mink Xpr1 without com-
promising its infectivity towards murine cells [10].
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determinant of species tropism exerts its function we
have investigated the binding of SL3-2 to non-permis-
sive cells and the interference pattern of wild type SL3-2
virus and its VR3 mutants on permissive murine cells.
Interference is the phenomenon of blocking entry recep-
t o r so fac e l lb ye n v e l o p ep r o t e i n sp r o d u c e dw i t h i nt h e
same cell. In other words, an envelope protein expressed
in a cell can bind to its receptor and thereby prevent
infection by viruses that use the same protein as recep-
tor [12]. Among the viruses that use the Xpr1 receptor,
those of the polytropic virus group have been found to
exhibit incomplete interference [13,14].
We find that wild type SL3-2 can bind to non-permis-
sive cells and thus has a post binding defect on human
cells. At the same time, this envelope is much less effi-
cient in interfering with viruses that use Xpr1; whereas
the R212G, T213I mutant (that has a wider tropism)
shows nearly complete interference. Since interference is
a consequence of receptor binding independent of the
fusiogenic activity of the envelope [15], we interpret
these data as evidence for a direct or indirect contribu-
tion of the VR3 loop to interaction with the Xpr1 recep-
tor. Interestingly, polytropic and xenotropic viruses
show similar non- reciprocal interference, suggesting
that these viruses bind with different affinities to differ-
ent parts of the Xpr1 receptor [13]. To our knowledge,
this is the first example of an interaction between
gamma-retroviral envelope and its receptor(s), which
primarily affects activation of the fusion machinery in a
receptor dependent manner.
Results
SL3-2 envelope binds to non-permissive human cells
As evident from Fig. 1, virions containing the wild type
mouse tropic SL3-2 envelope protein are still able to
bind to the non-permissive human cells in a receptor
dependent binding assay [16,17]. Hence the SL3-2 envel-
ope has a post-binding fusion deficiency on non-murine
cells. As such it is similar to another fusion deficient
variant of MLV envelope in which the H8R mutation
renders the protein non-fusogenic, but still able to bind
to permissive cells [17,18]. The residue at position 8
plays an important role in fusion activation regardless of
the receptor. A retargeted envelope protein shows the
same dependency as wt envelopes on this critical residue
[19]. The major difference between the phenotype
caused by mutations at positions 212 and 213 in the
SL3-2 envelope protein and histidine 8 mutants is that
in the case of SL3-2, the fusion deficiency is dependent
on the target cell and therefore most likely on the viral
receptor.
In this case, the VR3 loop should affect the interaction
between the envelope and receptor either by direct
binding or by causing conformational changes in the
overall envelope structure so as to affect this interaction
non-reciprocally. To clarify this issue, we wished to ana-
lyze the interference properties of the wild type or the
VR3 mutants of the SL3-2 envelope protein. Since inter-
ference is solely dependent on receptor binding, any
change in the mutants’ ability to cause interference is
direct evidence for alterations in binding to the receptor
caused by mutations in the VR3 loop.
Replication competent SL3-2 viruses
Measurement of relative interference properties requires
a sufficient level of envelope protein expression in all
target cells to allow for determinations of relative infec-
tivities above a background of infection of cells with low
or no envelope expression. This may be particularly
important in the case of polytropic viruses which have
been reported to exhibit incomplete interference proper-
ties [13,14]. We therefore constructed replication-com-
petent viruses that contain wild type or VR3 mutants of
SL3-2 envelope protein for use in interference experi-
ments. SL3-2 virus was isolated from a tumor cell line
from AKR mice, but no molecular clone of the original
virus exists, only the envelope gene has been cloned
[10,20]. Since the genome of SL3-2 is very similar to
SL3-3 virus except for the envelope gene [20], a replica-
tion competent virus containing the former envelope
was constructed by replacing the envelope gene of a
cloned SL3-3 virus with that of SL3-2 or its VR3
mutants. As can be seen in Fig. 2, NIH 3T3 cells
infected with these viruses constituted a uniformly
infected population with identical envelope expression
levels. To confirm the presence of the intended virus,
RNA was isolated from supernatants used for RT-PCR
using envelope primers, and the resulting fragments
were sequenced (data not shown). These cells were used
for determination of interference in the subsequent
studies.
The role of the VR3 loop in receptor blocking
In order to facilitate titer measurements, we used bi-cis-
tronic vectors that contain both a neomycin resistance
marker and the envelope gene. Vectors containing
envelopes from wt SL3-2, SL3-2 GI, SL3-2 MV or MCF
247 envelope genes were constructed previously as
described [10]. Glycine and isoleucine in the VR3 loop
are found in polytropic viruses (including MCF 247)
that have a wide tropism. Methionine and valine in VR3
loop have been selected for infectivity of human cells
from a randomized library. Both mutants infect human
and mink cells with wild type efficiency [10].
The vectors were co-transfected into 293T cells
together with a gag-pol expression plasmid. The super-
natants from these cells were used to transduce semi-
packaging cells which are derived from NIH 3T3 and
stably express Gag-Pol polyprotein from Moloney
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selected with G418 until a resistant population emerged.
These cells produce virions with the respective envel-
opes containing the bi-cistronic vector. The superna-
tants from semi-packaging cells were used for titer
measurements on the NIH 3T3 cells stably transduced
by replication competent SL3-2 viruses or NIH 3T3
cells containing MCF 247 virus. As negative control, we
used NIH 3T3 cells infected by the SL3-3 virus which
uses the ecotropic mCAT1 receptor [21] and does not
interfere with entry via Xpr1.
As can be seen in Fig. 3, the wt SL3-2 envelope is less
efficient in receptor blockage than are both SL3-2 MV
and SL3-2 GI, suggesting that the latter two envelopes
bind more strongly to the receptor than wt SL3-2. Inter-
estingly, MCF247 also contains glycine and isoleucine in
the VR3 loop and shows as efficient interference as does
the SL3-2 GI construct. Virions containing SL3-2 GI
envelope protein seem to be less sensitive to receptor
blockage by other polytropic viruses (with titers around
one order of magnitude larger than the other viruses).
This is consistent with the view that this envelope pro-
tein interacts more strongly with the receptor than wt
S L 3 - 2 .A l t h o u g ht h e s ed a t ad on o te x c l u d et h ep o s s i b i -
lity of interaction with a co-receptor, no direct evidence
for existence of one for murine gammaretroviruses
exists. Thus, glycine and isoleucine in the VR3 loop of
the envelope protein confer both an efficient superinfec-
tion resistance and also seem to enable the virus to
bypass receptor blockage slightly more efficiently.
Together this suggests that SL3-2 GI envelope has a
stronger interaction with the murine Xpr1. The methio-
nine and valine mutant SL3-2 MV that has originally
been selected from a library for infectivity on human
c e l l s[ 1 0 ]i si n f e r i o rt oS L 3 - 2G Ii nb l o c k i n gt h e
receptor. These amino acid residues are not found in
VR3 loops of any known wild type viruses. The effi-
ciency of MCF247 (which has glycine and isoleucine in
its VR3 loop) in conferring interference is expectedly
comparable to SL3-2 GI, but at the same time it seems
that SL3-2 GI is more capable of bypassing receptor
blockage suggesting better efficiency of infection than
that of MCF247. This is in agreement with our previous
observations that SL3-2 GI has a higher titer on both
mink and human cells than MCF247. Although there is
93% identity between SL3-2 and MCF247 envelope
sequences, there is only 80% identity between the VRB
regions of these two envelopes, suggesting involvement
of this region in receptor interaction. An alignment of
the envelope sequences can be found in [10].
Discussion
Murine gammaretroviruses that use Xpr1 as receptor
form a relatively diverse group, with significant differ-
ences in species tropism and non-reciprocal interference
patterns. Specifically, xenotropic and polytropic viruses
that both use the Xpr1 receptor seem to have affinity
for at least two different extracellular loops of the same
receptor [13,14,22]. The exact binding surface on the
polytropic/xenotropic/SL3-2 envelopes is not known,
but the N-terminal segment of SU containing the vari-
able region A (VRA) plays a role [23]. Binding to more
than one loop on the receptor suggests that these viral
envelopes must contain an accordingly large binding site
on their SUs; therefore, other sites on the envelope may
play roles. Here we present data that enforce our pre-
vious observations [10] that the composition of the VR3
loop influences the interaction with Xpr1.
T h eV R 3l o o ph a sp r e v i o u s l yb e e ns h o w nt ob e
involved in infectivity of human cells [10], but it was
Figure 1 Binding of virions containing the envelope protein of the SL3-2 MLV to permissive (NIH 3T3) and non-permissive (TE671)
cells. The cells were incubated with supernatants from cultures that either did or did not produce viral particles at 4°C and subsequently
labeled with anti-envelope antibodies for visualization in a flow-cytometer. (data are representative of several experiments). Light grey:
supernatant containing no virions, dark grey: virion containing supernatant.
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or post-binding steps. The facts that wt SL3-2 envelope
(with arginine and threonine in VR3 loop) can bind to
non-permissive cells together with inferring a much
reduced ability to block Xpr1 (on permissive murine
cells) from interaction with other viruses, suggest that
the VR3 loop affects the interaction between the envel-
ope and its receptor. One possibility is a direct binding
of VR3 to Xpr1. In this case, either this interaction is
not essential for successful infection of murine cells or
VR3 loops containing arginine and threonine can only
bind to the murine Xpr1. On human cells on the other
hand, it is conceivable that binding of wild type SL3-2 is
not strong enough without a positive contribution of the
VR3 loop to result in viral entry. Another possibility is
that the VR3 loop of the wt SL3-2, through steric hin-
drance, causes inefficient binding to non-murine Xpr1
receptors, which in not enough to activate the fusion
machinery of the envelope protein to allow entry. Alter-
natively, the presence of different amino acid residues in
VR3, can cause conformational changes in the rest of
the envelope in a way that affects its binding efficiency
to Xpr1, causing the aforementioned phenotypes.
It would be interesting to investigate whether SL3-2
ENV, even though it is not able to use non-murine
XPR1 receptors, can cause interference with other poly-
tropic viruses in non-permissive cells. To test this, we
cloned wt SL3-2 and SL3-2 GI mutant into an expres-
sion vector previously used for expression of high levels
of MLV envelope protein [24]. The resulting plasmids
were transfected into TE671 cells and selected with pur-
omycin until a resistance culture emerged that expresses
these envelope proteins. However, the expression levels
of ENV from these constructs were not high enough to
show any superinfection resistance. The notion that
repeated infections by a replication competent virus are
necessary for efficient interference to emerge in the case
of polytropic viruses is in agreement with the literature
[11,13,14]. This is in contrast to interference caused by
vector expression of the ecotropic envelope protein in
mouse cells where at least four orders of magnitude of
titer reduction of an incoming ecotropic vector particle
can be observed [10].
Interference occurs naturally in some mouse strains as
a defense against polytropic viruses (e.g. a xenotropic
provirus confers resistance to polytropic viruses in Mus
castaneus [25]). Interestingly, the endogenous viral
envelope that causes resistance to polytropic murine
leukemia virus infections in DBA/2 mice contains gly-
cine and threonine in the VR3 loop. Interference from
this envelope is only two orders of magnitude (which is
comparable to interference from SL3-2); yet it is enough
to inhibit spreading of polytropic viruses in these mice
[26].
Evidence from ecotropic and amphotropic viruses sug-
gest that VRA and VRB regions are directly involved in
interaction with the receptors. These two variable
regions as well as VR3 constitute three loops located in
close proximity on the surface of the SU subunit as
shown in crystal structures of receptor binding domains
of related envelope proteins of Friend murine leukemia
virus [27] and FeLV-B [28] (Fig. 4). It is therefore possi-
ble that VRA, VRB and VR3 loops constitute a binding
surface that interacts with the extracellular loops 3 and
4 of the Xpr1. According to such a model, a certain
Figure 2 Flow cytometric analysis of viral expression using
anti-envelope antibodies. Filled black: NIH3T3 (negative control),
filled grey SL3-3 (positive control). A) SL3-2 wildtype, B) SL3-2 GI and
C) SL3-2 MV.
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and the receptor is necessary for triggering the fusion
potential of TM, but how this affinity is distributed
between the three different loops is less important. The
non-reciprocal interference patterns observed in polytro-
pic and xenotropic viruses [13] and the different roles
that VR3 loop plays in binding to human or mouse
Xpr1, would then arise from the varying degrees with
which VRA, VRB and VR3 loops contribute to the over-
all binding affinity between envelope and receptor.
The receptor binding site of the ecotropic envelopes
seems to involve residues located in VRA [29]. It is
noteworthy that VRA in ecotropic envelopes is consider-
ably larger than in other murine leukemia virus isolates.
Interestingly, a conserved tryptophan (W142, see Fig. 4)
on the same surface of the protein as the VR3 loop has
also been implicated in receptor interaction [30], sup-
porting the idea that a large surface of the envelope pro-
tein must interact with the receptor to facilitate viral
entry. VR3 loop is flanked by W142 and VRA loop, and
the potential role for it in ecotropic viruses remains to
be investigated.
Overall our data suggest that the interaction between
the gammaretroviral envelope protein and its receptor,
at least in the case of the polytropic murine leukemia
viruses, is affected by the small VR3 loop. This interac-
tion is not critical for viral binding and is probably less
important than the interaction between the VRA and
Xpr1 for viral entry. However, amino acid substitutions
in the VR3 loop may modulate species tropism as well
as receptor interference pattern. This is an example of
an interaction between an envelope protein and its
receptor(s), which primarily affects activation of the
fusion machinery in a receptor dependent manner. The
results thereby suggest that simple binding to a receptor
protein is not sufficient for a successful fusion event,
but the interaction between the envelope protein and its
receptor must fulfill as yet undefined structural require-
ments for activation of the conformational changes that
result in membrane fusion.
Methods
Replication competent viruses
It has previously been shown that SL3-2 and the ecotro-
pic SL3-3 are closely related outside env [20]. Since no
complete clone of SL3-2 exists, replication competent
viruses were constructed by cloning of SL3-2 envelope
proteins into the SL3-3 MLV using standard cloning
techniques. The resulting viral genomes were transfected
into 293T cells and 48 h post transfection, supernatants
Figure 3 Interference pattern of different VR3 mutants of the SL3-2 Envelope protein. Murine cells chronically infected with replication
competent viruses were infected with virions containing different envelope mutants as well as a neo selection marker. 24 h post infection the
cells were selected by G418 until emergence of colonies. The figure shows the results for one of two independent experiments yielding smiliar
results.
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was confirmed by FACS. The MCF247 expressing NIH
cells were acquired separately [31].
RT-PCR
Supernatant from virus-producing cells was ultra-centri-
fuged for 90 minutes at 4°C and 25,000 rpm to pellet
the viral particles using an Optima L 80XP centrifuge
and SW41 rotor. The pellet was resuspended in 500 μl
TRIzol® reagent (Invitrogen) and RNA purified as
described by the manufacturer. cDNA was subsequently
produced using First-Strand cDNA Synthesis Kit (GE
Healthcare). 1-5 μg RNA and specific SL3-2 env reverse
primer (215066: 5’CGGGTCGGGAGGGGGGTAACT
3’) was used to produce cDNA, which was subsequently
amplified by PCR using SL3-2 env specific primers
(215066 and 212504: 5’TGCTAGCAGGGTGTG-
GAGGGC 3’). PCR fragments were purified and
sequenced using BigDye® Terminator v3.1 Cycle Sequen-
cing Kit, using primer 215066 and 212504 (Applied
Biosystems).
Flow cytometry analysis
Cells were released from plates, washed twice using PBS
with 2% serum and incubated with 500 μlo fs u p e r n a -
tant from the 83A25 [32] hybridoma cell line in 4°C for
45 minutes. The cells were subsequently washed twice,
and 5 μl of 1:40 diluted secondary antibody (Goat anti-
Rat Ig R-PE conjugate, Harlan Sera-Lab) were added to
the cell pellet. After incubation at 4°C for 45 minutes,
they were washed twice in PBS with 2% serum and sus-
pended in a 1% formalin solution and analyzed by a
Becton Dickinson FACSCalibur cytometer.
Virus binding assay
Virions were concentrated on a Centricon Plus-80 (100-
kDa cutoff) column and incubated with target cells at 4°
Cf o r4 5m i n u t e s .T h ec e l l swere washed twice using
PBS with 2% serum and incubated with 500 μl of super-
natant from 83A25 [32] hybridoma cell line in 4°C for
45 minutes. The cells were subsequently washed twice,
and 5 μl of secondary antibody (Goat anti-Rat Ig R-PE
conjugate, Harlan Sera-Lab) were added to the pellet of
cells. After incubation at 4°C for 45 minutes, they were
washed twice in PBS with 2% serum and suspended in a
1% formalin solution and analyzed by a Becton Dickin-
son FACSCalibur cytometer.
Titer measurements
Viral particles produced from semi-packaging cell lines
transduced by bi-cistronic vectors [33] bearing both neo
and env genes of SL3-2 wt, SL3-2 GI mutant, SL3-2 MV
mutant, or MCF 247 [10] were transferred to target
cells in serial 10-fold dilutions. After 25 h, the cells were
subjected to selection in medium containing 600 μg/mL
of G418 until colonies appeared. Titer data were con-
firmed in two independent experiments.
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